GlassScriptPhysician profile
Vaqar Ahmad
NPI 1225062359
$26,823.39
in general payments reported to CMS, 2019-2025
22 companies · $807 in 2025
The $807 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $7,621 · 2021: $4,916 · 2022: $527 · 2023: $243 · 2024: $560 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,568 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,567.69 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $24,434.55 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $339.08 | 2019-2025 | Jardiance, Mounjaro, Lyumjev |
| Mannkind Corporation | $316.87 | 2022-2025 | Afrezza |
| Xeris Pharmaceuticals, INC. | $305.44 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Insulet Corporation | $287.24 | 2021-2025 | Omnipod |
| Dexcom, INC. | $215.18 | 2020-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $122.90 | 2021-2025 | Tepezza, Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.63 | 2020-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $77.94 | 2021 | |
| Abbott Laboratories | $73.04 | 2020-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $69.70 | 2020-2025 | |
| Ascensia Diabetes Care US INC. | $59.86 | 2024 | |
| Ascendis Pharma Endocrinology INC | $54.00 | 2025 | Yorvipath |
| Ultragenyx Pharmaceutical INC. | $50.83 | 2023 | |
| Beta Bionics, INC. | $50.70 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $48.98 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Corcept Therapeutics | $46.63 | 2023-2025 | Korlym |
| Horizon Therapeutics Plc | $42.51 | 2022 | |
| Merck Sharp & Dohme LLC | $42.41 | 2020 | |
| Abbvie INC. | $33.32 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.16 | 2025 | |
| Esperion Therapeutics, INC. | $18.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vaqar Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.